Shuai Zhao

977 total citations
41 papers, 669 citations indexed

About

Shuai Zhao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shuai Zhao has authored 41 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Shuai Zhao's work include Cancer, Hypoxia, and Metabolism (10 papers), Cancer-related Molecular Pathways (7 papers) and Estrogen and related hormone effects (4 papers). Shuai Zhao is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Cancer-related Molecular Pathways (7 papers) and Estrogen and related hormone effects (4 papers). Shuai Zhao collaborates with scholars based in China, Japan and United States. Shuai Zhao's co-authors include Xiyun Yan, Yuichiro Kanno, Hongxia Duan, Kelong Fan, Yili Yang, Wafik S. El‐Deiry, Kiyomitsu Nemoto, Yoshio Inouye, Xuehui Chen and Naoya Yamashita and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Nano Letters.

In The Last Decade

Shuai Zhao

38 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuai Zhao China 14 273 173 120 106 100 41 669
Tian‐Huei Chu Taiwan 16 348 1.3× 132 0.8× 73 0.6× 59 0.6× 172 1.7× 41 774
Geng Xu China 14 183 0.7× 147 0.8× 62 0.5× 91 0.9× 119 1.2× 50 585
Michal Koc Czechia 17 327 1.2× 177 1.0× 65 0.5× 78 0.7× 93 0.9× 37 746
Deyao Shi China 16 377 1.4× 115 0.7× 71 0.6× 88 0.8× 195 1.9× 36 710
Wenping Lü China 14 198 0.7× 149 0.9× 78 0.7× 75 0.7× 96 1.0× 51 542
Junying Zheng United States 17 262 1.0× 77 0.4× 55 0.5× 59 0.6× 74 0.7× 28 625
Shuang Yan China 17 466 1.7× 215 1.2× 85 0.7× 72 0.7× 135 1.4× 50 801
Anindya Dey United States 17 482 1.8× 165 1.0× 95 0.8× 84 0.8× 184 1.8× 35 843
Weiguo Han United States 16 400 1.5× 113 0.7× 126 1.1× 88 0.8× 76 0.8× 38 779
Suvajit Sen United States 17 354 1.3× 82 0.5× 50 0.4× 81 0.8× 106 1.1× 29 744

Countries citing papers authored by Shuai Zhao

Since Specialization
Citations

This map shows the geographic impact of Shuai Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Zhao more than expected).

Fields of papers citing papers by Shuai Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Zhao. The network helps show where Shuai Zhao may publish in the future.

Co-authorship network of co-authors of Shuai Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai Zhao. A scholar is included among the top collaborators of Shuai Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai Zhao. Shuai Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Danfeng, Xiangqi Zhang, Shuai Zhao, et al.. (2025). Marsdenia tenacissima extract accelerates ferroptosis of osteosarcoma cells by upregulating HO-1 and activating mitophagy. Journal of Ethnopharmacology. 350. 120055–120055. 1 indexed citations
2.
Qu, Di, Shuai Zhao, Peng Qi, et al.. (2025). Diffractive lenses for neutron techniques. Scientific Reports. 15(1). 8408–8408.
3.
Cui, Lei, et al.. (2025). Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis. npj Precision Oncology. 9(1). 19–19. 2 indexed citations
4.
Youssef, Emile, et al.. (2024). Targeting the SMURF2-HIF1α axis: a new frontier in cancer therapy. Frontiers in Oncology. 14. 1484515–1484515. 3 indexed citations
5.
Lin, Sinan, Jie Wang, Pranab K. Mukherjee, et al.. (2023). Tu1246 CROHN'S DISEASE STRICTURE MATRISOME ANALYSIS REVEALS THE ANTI-FIBROTIC ACTIVITY OF MILK-FAT GLOBULE-EPIDERMAL GROWTH FACTOR 8 (MFGE8). Gastroenterology. 164(6). S–1006. 1 indexed citations
6.
Zhao, Shuai, Lanlan Zhou, David T. Dicker, et al.. (2021). Anti-cancer efficacy including Rb-deficient tumors and VHL-independent HIF1α proteasomal destabilization by dual targeting of CDK1 or CDK4/6 and HSP90. Scientific Reports. 11(1). 20871–20871. 13 indexed citations
7.
Zhou, Huiyuan, Yanlin Wu, Huanming Chen, et al.. (2020). Synthesis and Anti-tumor Activity of Novel Garcinol Analogs. Chinese Journal of Organic Chemistry. 40(6). 1578–1578. 1 indexed citations
8.
Duan, Hongxia, et al.. (2020). Targeting the CD146/Galectin-9 axis protects the integrity of the blood–brain barrier in experimental cerebral malaria. Cellular and Molecular Immunology. 18(10). 2443–2454. 23 indexed citations
10.
Zhao, Shuai, Hongxia Duan, Yili Yang, Xiyun Yan, & Kelong Fan. (2019). Fenozyme Protects the Integrity of the Blood–Brain Barrier against Experimental Cerebral Malaria. Nano Letters. 19(12). 8887–8895. 88 indexed citations
11.
Yamashita, Naoya, Nao Saito, Shuai Zhao, et al.. (2018). Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cells. Experimental Cell Research. 366(1). 34–40. 24 indexed citations
12.
Zhao, Shuai, Michael Cruise, Shardul Bhilocha, et al.. (2018). 626 - Selective Deletion of MYD88 Signaling in α-SMA Positive Cells Ameliorates Experimental Intestinal Fibrosis via Posttranscriptional Regulation. Gastroenterology. 154(6). S–130. 1 indexed citations
13.
Yamashita, Naoya, Shuai Zhao, Wei Li, et al.. (2017). Picrasidine G decreases viability of MDA-MB 468 EGFR-overexpressing triple-negative breast cancer cells through inhibition of EGFR/STAT3 signaling pathway. Bioorganic & Medicinal Chemistry Letters. 27(11). 2608–2612. 28 indexed citations
14.
Kanno, Yuichiro, Naoya Yamashita, Shuai Zhao, et al.. (2017). Alisol B 23-acetate from the rhizomes of Alisma orientale is a natural agonist of the human pregnane X receptor. Phytomedicine. 26. 22–27. 18 indexed citations
15.
Kanno, Yuichiro, Nobuhiro Tanuma, Shin Yazawa, et al.. (2016). Differences in Gene Regulation by Dual Ligands of Nuclear Receptors Constitutive Androstane Receptor (CAR) and Pregnane X Receptor (PXR) in HepG2 Cells Stably Expressing CAR/PXR. Drug Metabolism and Disposition. 44(8). 1158–1163. 6 indexed citations
16.
Zhao, Shuai, Yuichiro Kanno, Wei Li, et al.. (2016). Picrasidine N Is a Subtype-Selective PPARβ/δ Agonist. Journal of Natural Products. 79(4). 879–885. 23 indexed citations
17.
Zhao, Shuai, et al.. (2015). Evodiamine inhibits proliferation and induces apoptosis in gastric cancer cells. Oncology Letters. 10(1). 367–371. 28 indexed citations
18.
Zhao, Shuai & Jinhui Wu. (2013). Hypoxia Inducible Factor Stabilization As a Novel Strategy to Treat Anemia. Current Medicinal Chemistry. 20(21). 2697–2711. 12 indexed citations
20.
Zhao, Shuai, et al.. (2011). Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells. Cancer Letters. 317(2). 192–198. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026